Med-PaLM

Google · 2022 · Medical LLM · USA

A to Z

A · App: No
B · Built By: Google
C · CEO & Politics: Sundar Pichai — Centrist / historically bipartisan
D · Date: 2022
E · Expertise: Intermediate+
F · Free Tier: Yes
G · Generates: Text only
H · Deployment: Cloud
I · Inputs: Text
J · Jurisdiction: USA
K · Key Staffers: Jeff Dean (Chief Scientist), Sundar Pichai (CEO Alphabet)
L · Languages: English-primary
M · Model Type: Medical LLM
N · Safety Issues: None reported
O · Open Source: Proprietary
P · Pricing: Not sold (research model)
Q · AIDb Rating: [UNKNOWN]
R · What Makes It Special: Google Research's Med-PaLM, a medical question-answering model made by aligning Flan-PaLM (the instruction-tuned 540B-parameter PaLM) to medicine with instruction prompt tuning; preprinted in December 2022 and published in Nature in July 2023, it was the first AI system to pass (above 60%) US Medical Licensing Exam-style questions, though its authors found it still inferior to clinicians.
S · Stock / Status: $344 (GOOGL, Sep 25, 2026)
T · Training Cutoff: [UNKNOWN]
U · Users: [UNKNOWN]
V · Voice Chat: No
W · Weights: API only
X · X Handle: @Google
Y · Year Founded: [UNKNOWN]
Z · Bottom Line: Proprietary Medical LLM from Google, released 2022.

Data completeness 85% · Last verified 2026-05-12 · Primary source ↗

“Med-PaLM.” AIDb — The AI Database. Verified 2026-05-12. https://theaidatabase.com/m/med-palm.html